Skip to content

Embryo Culture Under Constant 5% vs Gradient 8%, 5%, 2% Oxygen Concentration

The Effect of Constant 5% Versus Gradient 8%, 5%, 2% Oxygen Concentration on the Development of Sibling Human Embryos in Vitro

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05898178
Enrollment
44
Registered
2023-06-12
Start date
2022-01-01
Completion date
2023-01-01
Last updated
2025-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Embryo Morphokinetics, Embryo Morphometry, Embryonic Development

Keywords

Embryo culture, reduced oxygen, time-lapse, blastocyst

Brief summary

The purpose of this study is to investigate the development of human embryos in vitro under two different oxygen concentrations; a static 5% during all five days of culture or under an oxygen gradient, starting with 8% from day-0 to day-3, continuing with 5% on day-3 and following with 2% of oxygen from the end of day-3 to day-5.

Detailed description

Several studies have shown that embryonic morphological parameters improved when the oxygen concentration in embryo culture was reduced from 20% to 5%. Early mammalian embryos developed faster, had shorter cell cycles, a higher blastocyst formation rate and a better integrity of the inner cell mass (ICM) compared to embryos cultured at 20% oxygen concentration. Recent studies have shown that the oxygen concentration in the female reproductive tract is not static. In the fallopian tubes of higher mammals it is at around 8%, while in the uterus, at the time of embryo implantation, the oxygen concentration is almost anoxic (2%). Mimicking such physiological conditions that better reflect the in vivo environment in the human reproductive tract is the goal of assisted reproductive technology (ART). The aim of this study is to assess whether changing the static 5% oxygen during five days of in vitro embryo culture to the gradient of oxygen, starting with 8% from day-0 to day-3, continuing with 5% on day-3 and following with 2% of oxygen from the end of day-3 to day-5, better reflects conditions found within the human reproductive tract and improves embryo developmental characteristics.

Interventions

OTHERExperimental intervention: 8-5-2% oxygen gradient concentration in the incubator

After oocyte retrieval and insemination, half of a given patient's embryos will be randomly allocated in an incubator set at a gradient of oxygen tension (8-5-2%). The embryos will remain in the incubator until their developmental assessments on day 5.

Sponsors

University Medical Centre Maribor
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Masking description

The cohort of oocyte-cumulus complexes will be divided into either the study or control group by simple randomization. All embryologists involved in the study will be blinded during embryo assessment, measurement, and selection for embryo transfer or vitrification. A code system will be used on the Petri dishes to ensure the embryologists are blinded.

Intervention model description

496 sibling oocytes will be randomly allocated for culture either at low oxygen tension (5% O2) (n = 248 oocytes) or a more physiological oxygen gradient (8-5-2% O2) (n = 248 oocytes) for the next 5 days. Immediately after allocation, the oocytes will be inseminated through Intracytoplasmic Sperm Injection (ICSI). The sibling oocytes will always be injected by the same embryologist. Under standard (5%) oxygen concentration, which is currently being used in the cultivating incubators, approximately 15% of all embryos manage to reach a morphological optimal blastocyst, in a patient group younger than 35 years (see Inclusion Criteria). According to the hypothesis that cultivating embryos under a more physiological atmosphere (gradient from 8% to 2%) improves the blastulation rate of embryos to 25%, a sample size of 496 Injected oocytes (248 in each arm), will be needed. Whereby a statistical strength of 80% and α = 0.05 is considered (calculated using power analysis).

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Age of women between 18 and 35 years. * Body mass index (BMI) between 18 and 30 kg/m². * Only patients with ICSI procedure (male factor of infertility, excluding azoospermia) and blastocyst culture. * Patients from first and second ICSI cycle attempt. * Gonadotropin hormone-releasing hormone (GnRH) antagonist cycles.

Exclusion criteria

* Presence of endometriosis. * Previous clinical intervention on ovaries. * Connected endocrine or metabolic diseases. * Presence of polycystic ovary syndrome.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Inseminated Oocytes Developed to the Morphologically Optimal Blastocysts on Day 5Embryos will be annotated on day 5 post insemination (at 8:00 am).The primary outcome measure will be the proportion of oocytes that will develop to the morphologically optimal day-5 blastocysts, scored 4-5AA according to Gardner criteria. According to the scoring system of Gardner, blastocyst morphology parameters such as the degree of blastocoel expansion (1-5), the morphological appearance of the inner cell mass (ICM) (A, B, C) and the cohesiveness of trophectoderm (TE) (A, B, C) will be measured.

Secondary

MeasureTime frameDescription
Measured Times From Insemination to Different Embryonic Stages ReachedMorphokinetic timings were recorded continuously (every 5 minutes) throughout embryo culture, up to 124 hours (Day 5) post-insemination.Using time-lapse software, embryo development videos were reviewed by manually advancing the images frame by frame. Morphokinetic timings were recorded continuously (every 5 minutes) throughout embryo culture, up to 124 hours (Day 5) post-insemination. The following developmental milestones were recorded for each clinically used embryo that reached the blastocyst stage (cryopreserved or transferred): tPNa - Appearance of individual pronuclei t2 - Time to 2-cell stage t3 - Time to 3-cell stage t4 - Time to 4-cell stage t5 - Time to 5-cell stage t6 - Time to 6-cell stage t7 - Time to 7-cell stage t8 - Time to 8-cell stage tSC - First evidence of compaction tM - Completion of the compaction process (morula stage) tSB - Initiation of blastulation tB - Full blastocyst (last frame before zona pellucida starts to thin) tEB - Initiation of blastocyst expansion (first frame showing zona thinning)
Blastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5Fix time (116 hours) post inseminationSurface measurements of blastocysts and inner cell mass (ICM) will be recorded on time-lapse photos at 116 hours after insemination. The surfaces will be measured in square micrometres using the Primo vision software's measuring tool. An ellipse will be generated around the trophectoderm's outer edge or the inner cell mass. These measurements will exclude the zona pellucida. The measurements will be taken at the focus plane with the largest surface area.
Number of Trophectoderm Cells on Day 5Fix time (116 hours) post insemination.At 116 hours following insemination, the number of trophectoderm cells will be counted using time-lapse photos. Images will be focused on the trophectoderm's outermost edge to better determine the boundaries of each individual cell.
Incidence of Atypical Embryo CleavagesContinuously (a picture will be taken every 5 minutes) during 5 days of embryo culture.Time-lapse videos for each embryo will be reviewed for atypical cleavage features, such as; pseudofurrows, direct cleavage, reverse cleavage, multinucleation, irregular chaotic division, cell exclusion and blastocyst collapse, using Primo vision software by manually forwarding the images frame by frame. The frequency of abnormal cleavage patterns will be recorded.

Countries

Slovenia

Participant flow

Recruitment details

Participants were recruited between January 2022 and January 2023 at the University Medical Centre Maribor. Women under 35 undergoing ICSI for male infertility were included. All patients provided informed consent. A total of 44 participants were enrolled, with a total of 658 cumulus-oocyte complexes (COCs) collected.

Pre-assignment details

Following oocyte pickup, 625 cumulus-oocyte complexes from 44 ICSI cycles were allocated to two groups by quasi randomisation. After excluding immature (GV/MI) or degenerated oocytes, 521 metaphase II (MII) oocytes remained, with 258 assigned to the control group (5% O₂) and 263 to the intervention group (8-5-2% O₂).

Participants by arm

ArmCount
All Study Participants
As a sibling oocyte study, individual patients were not assigned to groups; instead, all 44 enrolled female patients had their sibling oocytes allocated between the intervention and control conditions. Thus, a single cohort of patients served as the baseline population.
44
Total44

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous31.4 Years
STANDARD_DEVIATION 2.36
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
44 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Proportion of Inseminated Oocytes Developed to the Morphologically Optimal Blastocysts on Day 5

The primary outcome measure will be the proportion of oocytes that will develop to the morphologically optimal day-5 blastocysts, scored 4-5AA according to Gardner criteria. According to the scoring system of Gardner, blastocyst morphology parameters such as the degree of blastocoel expansion (1-5), the morphological appearance of the inner cell mass (ICM) (A, B, C) and the cohesiveness of trophectoderm (TE) (A, B, C) will be measured.

Time frame: Embryos will be annotated on day 5 post insemination (at 8:00 am).

Population: The primary outcome measure is the proportion of inseminated MII oocytes that develop into morphologically optimal day-5 blastocysts, defined as grade 4-5AA according to the Gardner criteria and not the enrolled patient coupled (n=44)

ArmMeasureValue (NUMBER)
8-5-2% Oxygen Gradient Concentration in the IncubatorProportion of Inseminated Oocytes Developed to the Morphologically Optimal Blastocysts on Day 527 Oocytes
Control (no Intervention)Proportion of Inseminated Oocytes Developed to the Morphologically Optimal Blastocysts on Day 538 Oocytes
Secondary

Blastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5

Surface measurements of blastocysts and inner cell mass (ICM) will be recorded on time-lapse photos at 116 hours after insemination. The surfaces will be measured in square micrometres using the Primo vision software's measuring tool. An ellipse will be generated around the trophectoderm's outer edge or the inner cell mass. These measurements will exclude the zona pellucida. The measurements will be taken at the focus plane with the largest surface area.

Time frame: Fix time (116 hours) post insemination

Population: Blastocysts graded Gardner ≥3 were included, as they exhibited sufficient morphological development for accurate measurement of blastocyst and inner cell mass (ICM) surface areas.

ArmMeasureGroupValue (MEAN)Dispersion
8-5-2% Oxygen Gradient Concentration in the IncubatorBlastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5Blastocyst surface area (P, µm²)25994 µm²Standard Deviation 4657
8-5-2% Oxygen Gradient Concentration in the IncubatorBlastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5Inner cell mass surface area (ICM, µm²)3695 µm²Standard Deviation 732.5
Control (no Intervention)Blastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5Blastocyst surface area (P, µm²)28198 µm²Standard Deviation 4139
Control (no Intervention)Blastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5Inner cell mass surface area (ICM, µm²)3628 µm²Standard Deviation 831.9
Secondary

Incidence of Atypical Embryo Cleavages

Time-lapse videos for each embryo will be reviewed for atypical cleavage features, such as; pseudofurrows, direct cleavage, reverse cleavage, multinucleation, irregular chaotic division, cell exclusion and blastocyst collapse, using Primo vision software by manually forwarding the images frame by frame. The frequency of abnormal cleavage patterns will be recorded.

Time frame: Continuously (a picture will be taken every 5 minutes) during 5 days of embryo culture.

Population: The analysis included all embryos that progressed to the blastocyst stage.

ArmMeasureGroupValue (NUMBER)
8-5-2% Oxygen Gradient Concentration in the IncubatorIncidence of Atypical Embryo CleavagesPseudofurrows36 Number of events
8-5-2% Oxygen Gradient Concentration in the IncubatorIncidence of Atypical Embryo CleavagesDirect cleavage25 Number of events
8-5-2% Oxygen Gradient Concentration in the IncubatorIncidence of Atypical Embryo CleavagesReverse cleavage14 Number of events
8-5-2% Oxygen Gradient Concentration in the IncubatorIncidence of Atypical Embryo CleavagesIrregular chaotic division21 Number of events
8-5-2% Oxygen Gradient Concentration in the IncubatorIncidence of Atypical Embryo CleavagesBlastomere exclusion45 Number of events
8-5-2% Oxygen Gradient Concentration in the IncubatorIncidence of Atypical Embryo CleavagesBlastocyst collapse55 Number of events
Control (no Intervention)Incidence of Atypical Embryo CleavagesBlastomere exclusion34 Number of events
Control (no Intervention)Incidence of Atypical Embryo CleavagesPseudofurrows49 Number of events
Control (no Intervention)Incidence of Atypical Embryo CleavagesIrregular chaotic division15 Number of events
Control (no Intervention)Incidence of Atypical Embryo CleavagesDirect cleavage30 Number of events
Control (no Intervention)Incidence of Atypical Embryo CleavagesBlastocyst collapse67 Number of events
Control (no Intervention)Incidence of Atypical Embryo CleavagesReverse cleavage9 Number of events
Secondary

Measured Times From Insemination to Different Embryonic Stages Reached

Using time-lapse software, embryo development videos were reviewed by manually advancing the images frame by frame. Morphokinetic timings were recorded continuously (every 5 minutes) throughout embryo culture, up to 124 hours (Day 5) post-insemination. The following developmental milestones were recorded for each clinically used embryo that reached the blastocyst stage (cryopreserved or transferred): tPNa - Appearance of individual pronuclei t2 - Time to 2-cell stage t3 - Time to 3-cell stage t4 - Time to 4-cell stage t5 - Time to 5-cell stage t6 - Time to 6-cell stage t7 - Time to 7-cell stage t8 - Time to 8-cell stage tSC - First evidence of compaction tM - Completion of the compaction process (morula stage) tSB - Initiation of blastulation tB - Full blastocyst (last frame before zona pellucida starts to thin) tEB - Initiation of blastocyst expansion (first frame showing zona thinning)

Time frame: Morphokinetic timings were recorded continuously (every 5 minutes) throughout embryo culture, up to 124 hours (Day 5) post-insemination.

Population: Embryos included in the analysis were those that progressed to the blastocyst stage and were deemed suitable for clinical use, either through transfer or cryopreservation.

ArmMeasureGroupValue (MEDIAN)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages Reachedt336.6 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages Reachedt869.5 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages Reachedt549.5 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages ReachedtSC86.0 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages Reachedt225.7 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages ReachedtM91.2 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages Reachedt653.2 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages ReachedtSB106.1 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages Reachedt438.8 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages ReachedtB112.4 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages Reachedt761.5 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages ReachedtEB117.0 Hours post-insemination (HPI)
8-5-2% Oxygen Gradient Concentration in the IncubatorMeasured Times From Insemination to Different Embryonic Stages ReachedtPNa11.4 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages ReachedtEB111.4 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages ReachedtPNa11.7 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages Reachedt225.7 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages Reachedt335.1 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages Reachedt437.6 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages Reachedt548.1 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages Reachedt653.1 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages Reachedt763.4 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages Reachedt871.9 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages ReachedtSC83.8 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages ReachedtM88.3 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages ReachedtSB100.8 Hours post-insemination (HPI)
Control (no Intervention)Measured Times From Insemination to Different Embryonic Stages ReachedtB106.9 Hours post-insemination (HPI)
Secondary

Number of Trophectoderm Cells on Day 5

At 116 hours following insemination, the number of trophectoderm cells will be counted using time-lapse photos. Images will be focused on the trophectoderm's outermost edge to better determine the boundaries of each individual cell.

Time frame: Fix time (116 hours) post insemination.

Population: Blastocysts graded Gardner ≥3 were included, as these embryos exhibited sufficient morphological development to enable accurate count of trophectoderm (TE) cell number.

ArmMeasureValue (MEAN)Dispersion
8-5-2% Oxygen Gradient Concentration in the IncubatorNumber of Trophectoderm Cells on Day 514.4 Number of cellsStandard Deviation 2.3
Control (no Intervention)Number of Trophectoderm Cells on Day 515.3 Number of cellsStandard Deviation 2.8

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026